Chih‐Chung Lin

2.6k citations
66 papers · 2.1k indexed · h-index 29
Topics
NF-κB Signaling Pathways (15 papers)Inflammatory mediators and NSAID effects (10 papers)Immune Response and Inflammation (9 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Chih‐Chung Lin

66 papers receiving 2.1k citations

Peers

Chih‐Chung Lin
Comparison fields: 5 of 139
  • Molecular Biology 776
  • Immunology 375
  • Cancer Research 346
  • Surgery 313
  • Physiology 234
Replace Jun Tao with:
Jun Tao China
Ziqing Hei China
Farhad R. Danesh United States
Shinya Minatoguchi Japan
Martin Albrecht Germany
Teemu Moilanen Finland
Zhongqing Chen China
Ilkka Tikkanen Finland
Jingjing Zhang China
Hongtao Wang China
Chih‐Chung Lin relative to Jun Tao China Jun Tao's profile →
Citations per field
00.5×1.6×
Jun Tao · 1×
Citations per year

Countries citing papers authored by Chih‐Chung Lin

Since Specialization
Citations

This map shows the geographic impact of Chih‐Chung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Chung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Chung Lin more than expected).

Fields of papers citing papers by Chih‐Chung Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Chung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Chung Lin. The network helps show where Chih‐Chung Lin may publish in the future.

Co-authorship network of co-authors of Chih‐Chung Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Chung Lin. A scholar is included among the top collaborators of Chih‐Chung Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Chung Lin. Chih‐Chung Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 3
3 6
4 12
5 15
6 28
7 51
8 23
9 17
10 26
11 8
12 38
13 9
14 25
15 43
16 95
17 29
18 120
19 64
20 36

About Chih‐Chung Lin

Chih‐Chung Lin is a scholar working on Anesthesiology and Pain Medicine, Cancer Research and Immunology and Allergy, having authored 66 papers that have together received 2.1k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (15 papers), Inflammatory mediators and NSAID effects (10 papers) and Immune Response and Inflammation (9 papers). The work is most often cited by research in Cancer Research (346 citations), Anesthesiology and Pain Medicine (101 citations) and Immunology (375 citations). Chih‐Chung Lin has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Chuen‐Mao Yang, Li‐Der Hsiao, Chiang‐Wen Lee, Chin‐Sung Chien, Hsi‐Lung Hsieh, Wei‐Ning Lin, Shue‐Fen Luo, I‐Ta Lee, Pei‐Ling Chi and Chi‐Tso Chiu. Their work appears in journals such as Renewable and Sustainable Energy Reviews, PLoS ONE and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026